New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom

References

• House of LordsNo vaccine, no cure: HIV and AIDS in the United Kingdom Available from: http://www.publications.parliament.uk/pa/ld201012/ldselect/ldaids/188/188.pdfAccessed May 30, 2012
   Google Scholar
• Health Protection AgencyHIV in the United Kingdom: 2011 report Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317131685847Accessed May 30, 2012
   Google Scholar
• British HIV AssociationBHIVA guidelines for the treatment of adult HIV-1 infected adults with antiretroviral therapy2012 Available from: http://www.bhiva.org/documents/Guidelines/Treatment%20Guidelines/2012/formatted__ART_guidelines_04022012_v3_IW.pdfAccessed May 30, 2012
   Google Scholar
• European AIDS Clinical SocietyGuidelines for the clinical management of HIV infected adults in Europe Available from: http://www.europeanaidsclinicalsociety.org/index.php?option=com_content&view=article&id=59&Itemid=41Accessed May 30, 2012
   Google Scholar
• Department of Health and Human SciencesAIDS infoGuidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents Available at: http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/37/whats-new-in-the-guidelines-Accessed May 30, 2012
   Google Scholar
• NakagawaFLodwickRSmithCProjected life expectancy of people with HIV according to timing of diagnosisAIDS201226333534322089374
   PubMed Web of Science ®Google Scholar
• CohenMChenYMcCauleyMPrevention of HIV-1 infection with early antiretroviral therapyN Engl J Med2011365649350521767103
   PubMed Web of Science ®Google Scholar
• AIDS InfoClinical Guidelines Portal Available at: http://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?GuidelineID=387&ClassID=4Accessed October 21, 2011
   Google Scholar
• OlsenCHGatellJLedergerberBRisk of AIDS and death at given HIV-RNA and CD4 cell counts, in relation to specific antiretroviral drugs in the regimenAIDS200519331933015718843
   PubMed Web of Science ®Google Scholar
• The PLATO Collaboration2004Predictors of trend in CD4 positive T-cell count and mortality among HIV-1 infected individuals with virological failure to all three antiretroviral drug classesLancet20043649492516215234856
   PubMed Web of Science ®Google Scholar
• MeePFieldingKCharalambousSChurchyardGJGrantADEvaluation of the WHO criteria for antiretroviral treatment failure among adults in South AfricaAIDS200822151971197718784460
   PubMed Web of Science ®Google Scholar
• ReynoldsSKakigoziGNewellKFailure of immunologic criteria to appropriately identify antiretroviral treatment failure in UgandaAIDS200923669770019209067
   PubMed Web of Science ®Google Scholar
• MocroftAPhillipsAGatellJNormalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyLancet2007370358540741317659333
   PubMed Web of Science ®Google Scholar
• PhillipsAYouleMLampeFCD4 cell count changes in individuals with counts above 500 cells/mm3 and viral loads below 50 copies/mL on antiretroviral therapyAIDS20021671073107511953476
   PubMed Web of Science ®Google Scholar
• ChiltonDNeuhausJPalfreemanAUtility of CD4 count monitoring in patients on HAART who maintain viral load suppression – experience from the VS arm of the SMART studyAbstract O21 presented at the Fourteenth British HIVAssociation ConferenceApril 23–25, 2008Belfast, Ireland
   Google Scholar
• The UK Collaborative Group on HIV Drug Resistance, UK CHIC Study GroupLong term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practiceAIDS200519548749415764854
   PubMed Web of Science ®Google Scholar
• Medecins Sans FrontieresUntangling the web of antiretroviral price reductions: a pricing guide for the purchase of ARVs for developing countries12th ed prepublication price analysis72009 Available at: http://www.msfaccess.org/content/untangling-web-antiretroviral-price-reductions-14th-edition
   Google Scholar
• British National FormularyBNF5732009 Available from: http://www.esoph.org/af/books/BNF%2057.pdfAccessed May 30, 2012
   Google Scholar
• United PharmaciesCost of generic 3TC and ZDV in the UK (60 tablets) Available from: http://www.unitedpharmacies-uk.com/3TC_150mg_60_Tablets_p_891.htmlAccessed May 30, 2012
   Google Scholar
• Grupo de Estudio de SIDA Expert Panel and the National AIDS PlanGESIDA consensus document/Spanish AIDS plan regarding antiretroviral treatment in adults with human immunodeficiency virus infectionSpanish Available from: http://www.gesida.seimc.org/pcientifica/dcconsensos.aspAccessed May 30, 2012
   Google Scholar
• Cost of generic nevirapine in UK Available from: http://www.unitedpharmacies-uk.com/Nevimune_Nevirapine_200mg_10_Tablets_p_369.html
   Google Scholar
• OrtizRDeJesusEKhanlouHEfficacy and safety of oncedaily darunavir/ritonavir versus lopinavir-ritonavir in treatment naïve HIV-1 infected patients at Week 48AIDS200822121389139718614861
   PubMed Web of Science ®Google Scholar
• MolinaJAndrade-VillanuevaJEcheverriaJOnce-daily atazanavir-ritonavir compared with twice-daily lopinavir-ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1 infected patients: 96 week efficacy and safety results of the CASTLE studyJ Acquir Immune Defic Syndr200953332333220032785
   PubMed Web of Science ®Google Scholar
• GallantJDeJesusEArribasJTenofovir DF, emtricitabine and efavirenz vs zidovudine, lamivudine and efavirenz for HIVN Engl J Med2006354325126016421366
   PubMed Web of Science ®Google Scholar
• MoyleGSabinCCartledgeJA randomised comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophyAIDS200620162043205017053350
   PubMed Web of Science ®Google Scholar
• van LethFPhanuphakPRuxrungthamKComparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyLancet200436394171253126315094269
   PubMed Web of Science ®Google Scholar
• SorianoVArastehKMigroneHNevirapine versus atazanavir/ritonavir each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN trialAntivir Ther201116320402058
   Web of Science ®Google Scholar
• ArribasJClumeckNNelsonMThe MONET trial: week 144 analysis of efficacy of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs, for patients with HIV RNA < 50 copies/mL at baselineAbstract MOPE215 presented at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and PreventionJuly 17–20, 2011Rome, Italy
   Google Scholar
• KatlamaCValentinMAAlgarte-GeninMEfficacy of darunavir/ritonavir as single-drug maintenance therapy in patients with HIV-1 viral suppression: a randomized open-label non-inferiority trial, MONOIANRS 136AIDS201024152365237420802297
   PubMed Web of Science ®Google Scholar
• GuaraldiGZonaSCossarizzaAImpact of switching to darunavir/ritonavir monotherapy vs triple-therapy on body fat redistribution and bone mass in virologically suppressed HIV-infected adults. The MONARCH randomized controlled trialAbstract PE7.5/4 presented at the 13th European AIDS ConferenceOctober 12–15Belgrade, Serbia2011
   Google Scholar
• GazzardBHillAAnceauACost-efficacy analysis of the MONET Trial using UK antiretroviral drug pricesAppl Health Econ Health Policy20119421722321682350
   PubMedGoogle Scholar
• BiermanWFvan AgtmaelMANijhuisMDannerSABoucherCAHIV monotherapy with ritonavir-boosted protease inhibitors: a systematic reviewAIDS200923327929119114854
   PubMed Web of Science ®Google Scholar
• UK Medical Research CouncilA randomised controlled trial of a strategy of switching to boosted protease inhibitor monotherapy versus continuing combination antiretroviral therapy for the long-term management of HIV-1 infected patients who have achieved sustained virological suppression on highly-active antiretroviral therapy Available from: http://www.controlled-trials.com/ISRCTN04857074Accessed May 30, 2012
   Google Scholar